PDCD1 and cancer: Likewise, Karam and colleagues reported that infection‐free survival was similar between those with and without corticosteroid/immunosuppressant use before initiation of immune checkpoint inhibitors (primarily targeting PD‐1/PD‐L1) in cancer patients.9